Product Images Bupivacaine Hydrochloride And Epinephrine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 31 images provide visual information about the product associated with Bupivacaine Hydrochloride And Epinephrine NDC 0409-9043 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Hospira Logo - bupivacaine 01

Hospira Logo - bupivacaine 01

structural formula bupivacaine hydrochloride - bupivacaine 02

structural formula bupivacaine hydrochloride - bupivacaine 02

structural formula epinephrine - bupivacaine 03

structural formula epinephrine - bupivacaine 03

Hospira Logo - bupivacaine 04

Hospira Logo - bupivacaine 04

This is a description of a medication containing 0.25% Bupivacaine HCI and epinephrine, which is used for infiltration and nerve block only. The medication is packaged in a 50 mL vial with a headspace filled with inert gas and a preservative. The label includes information on storage temperature, concentration, and warning about sulfites. The medication is distributed by Hospira in Lake Forest, Illinois. There is information on the lot number and expiration date; however, these details are not available in the text.*

PRINCIPAL DISPLAY PANEL - 100 mg/20 mL Ampul Container Label - bupivacaine 05

PRINCIPAL DISPLAY PANEL - 100 mg/20 mL Ampul Container Label - bupivacaine 05

This is a description for a medication containing bupivacaine hydrochloride and epinephrine. It can only be used for nerve block and infiltration but not for spinal, caudal or epidural anesthesia. The medication comes in a 50ml bottle and should be stored at room temperature between 15°C and 30°C. It contains sulfites and should be protected from light. The usual dose is not specified, although there is an insert with that information. It is not recommended to use the injection if it appears pinkish or has a darker color than slightly yellow, or if it contains precipitate.*

carton NDC 0409-4273-01 - bupivacaine 06

carton NDC 0409-4273-01 - bupivacaine 06

This is a description for a medication that comes in a single-dose vial of 10 milliliters. It is a prescription-only medicine containing bupivacaine hydrochloride at a concentration of 0.5% and epinephrine. This medication is specifically for nerve block, caudal, and epidural anesthesia with a usual dosage as noted by a health care professional. It's a Hospira-distributed medicine that has an NDC number of 0409-9045-11, and the unused portion must be discarded. It's a warning that the medication contains sulfites, and it's not for autodave. The medication is composed of bupivacaine KO, anhyd 5 mg; epinephrine 5 meg; NaC18.5 mg; sodium disodium, anhyd. 0.1 mg added. The pH is adjusted with NaOH andjor HO to a level around 4.0(33105.5). The medication should not be used if discolored or has a precipitate. The appropriate storage condition is at controlled room temperature and protecting it from light. The lot number is HH-##H#H-AA, with an expiry date of DMMMYYYY.*

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Label - 9043 - bupivacaine 07

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Label - 9043 - bupivacaine 07

This text appears to be a description of a medication product, which is a 10mL single-dose tear-top vial containing 0.5% Bupivacaine Hydrochloride with epinephrine injection, intended for nerve block, caudal and epidural anesthesia only, not for spinal anesthesia. The medication must be used as per aseptic technique and requires sterilization before use. It is advised to discard any unused portion of the solution. The medication contains sulfites and should be protected from freezing and light. The package's Lot #, expiration date, and GTIN are mentioned, and the recommended storage temperature range is specified. However, there is also some unreadable text that may affect the accuracy of the description.*

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Carton - bupivacaine 08

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Carton - bupivacaine 08

This is a description of a medication in a 50 mL multiple-dose vial. The medication is an injection containing 0.5% Bupivacaine HCl, Epinephrine, and other additives. The medication is sterile and nonpyrogenic but should not be autoclaved. The usual dose is indicated in the insert, and the injection should not be used if it appears discolored or cloudy. The medication should be stored at room temperature and protected from freezing and light. The product is distributed by RL-7487 and contains sulfites. A warning label indicates that the medication is for nerve block only. Lot and expiration information is also included.*

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Label - bupivacaine 09

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Label - bupivacaine 09

This is a product label for a sterile and nonpyrogenic injection containing 0.5% Bupivacaine Hydrochloride and epinephrine used for nerve block only. It is not suitable for epidural or spinal anesthesia. The injection should not be used if its color is pinkish or darker than slightly yellow or if it contains a precipitate. The warning on the label indicates that it contains sulfites. It also contains other ingredients such as sodium chloride, sodium metabisulfite, methylparaben, and calcium disodium edetate.*

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Carton - bupivacaine 10

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Carton - bupivacaine 10

This is a description of a medication contained in a 10 mL single-dose teartop vial. The medication contains epinephrine and bupivacaine hydrochloride (HCl) with other ingredients like NaCl and edetate clcum. The injection is used for infiltration, nerve block, caudal and epidural anesthesia. The injection should not be used if it is discolored or contains precipitates. The medication should be stored at a controlled room temperature of 20-25°C and protected from light. The label also contains information on the lot number and expiration date. The medication is distributed by Hospira, Inc. However, it also contains a warning that it is not available if the text is not readable.*

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Label - 9046 - bupivacaine 11

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Label - 9046 - bupivacaine 11

The provided text describes a medication by the name of "Esch L". It contains bupivacaine, epinephrine, sodium chloride, and sodium metabisulfite as an antioxidant. It also contains edetate calcium disodium as a stabilizer. The medication is not for spinal anesthesia, and it should be protected from freezing. It is a single dose, and unused portions should be discarded. The medication comes in a 10 mL container and is for infiltration, nerve block, caudal, and epidural anesthesia. It also has a warning label about sulfites and comes packaged with a lot number and expiration date.*

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Carton - bupivacaine 12

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Carton - bupivacaine 12

This is a description of a 10 mL single-dose Teartop Vial containing 0.25% Bupivacaine Hydrochloride Injection, USP with 25 mg/10 mL (2.5 mg/mL) concentration. This vial is preservative-free and is useful for infiltration, nerve block, caudal, and epidural anesthesia, but not suitable for spinal anesthesia. Each mL of the injection contains bupivacaine HCI, anhydrous 2.5 mg, NaCl 8.6 mg, and may contain NaOH and/or HCl for pH adjustments. The injection is sterile, nonpyrogenic, and is available only on prescription. The usual dosage and the route of administration are mentioned in the insert, and the vial is recommended to be stored in temperatures ranging from 20 to 25°C (68 to 77°F) as controlled by the USP. The manufacturer of this injection is Hospira, Inc, located in Lake Forest, IL 60045 USA, and the product is distributed by RL-7460. The LOT #H-#HH#H-AA and EXP DMMMYYYY are also mentioned.*

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Label - 9042 - bupivacaine 13

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Label - 9042 - bupivacaine 13

Each mL of a clear solution contains bupivacaine hydrochloride. The product is meant to be stored at 20°C to 25°C, with excursions permitted. The solution contains hydroxide and/or hydrochloric acid for pH adjustment. The dosage and volume of the injection are not provided. The text includes some copyrighted material in the form of a logo and several codes, but it's not available for interpretation.*

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Carton - bupivacaine 14

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Carton - bupivacaine 14

This is a description for a single-dose vial of 0.25% Bupivacaine Hydrochloride Injection, USP. The vial has a volume of 30mL and is preservative-free. Each mL contains 2.5 mg of bupivacaine HCl and 8.6 mg of sodium chloride. The pH can be adjusted using NaOH and/or HCl. The injection is sterile, nonpyrogenic and is intended for infiltration, nerve block, caudal and epidural anesthesia. It should not be used for spinal anesthesia. This product is distributed by Hospira and the lot number, expiry date, and storage temperature are provided.*

PRINCIPAL DISPLAY PANEL - 75 mg/30 mL Ampul Label - bupivacaine 15

PRINCIPAL DISPLAY PANEL - 75 mg/30 mL Ampul Label - bupivacaine 15

This text is a product label for a 30mL single-dose vial of 0.25% Bupivacaine hydrochloride injection, USP. It contains instructions for use, including the need for aseptic technique, and information on the product's NDC number and dosage strength. It also indicates that the vial is preserved-free and provides a code for tracking purposes.*

PRINCIPAL DISPLAY PANEL - 75 mg/30 mL Ampul Carton - bupivacaine 16

PRINCIPAL DISPLAY PANEL - 75 mg/30 mL Ampul Carton - bupivacaine 16

This is a description of a medication called 0.25% Bupivacaine Hydrochloride Injection USP containing 125 mg/50 mL (2.5 mg/mL) which is suitable for infiltration and nerve block but not for caudal, epidural or spinal anesthesia. It is administered via the usual dosage and route mentioned in the insert. The medication is stored at a temperature of 20-25°C (68-77°F) and is sterile and non-pyrogenic. It has bupivacaine hydrochloride, sodium chloride, methylparaben, and NaOH or HCl (for pH adjustment) as constituents. It is distributed by Hospira, Inc. in Lake Forest, IL 60045 USA and its NDC number is 0409-1160-18. The lot number and expiry date are also mentioned in the text.*

PRINCIPAL DISPLAY PANEL - 150 mg/30mL Ampul Label - bupivacaine 17

PRINCIPAL DISPLAY PANEL - 150 mg/30mL Ampul Label - bupivacaine 17

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Ampul Carton - bupivacaine 18

PRINCIPAL DISPLAY PANEL - 150 mg/30 mL Ampul Carton - bupivacaine 18

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Label-1159 - bupivacaine 19

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Label-1159 - bupivacaine 19

Each mL of the solution includes bupivacaine hydrochloride. The product is sterile and non-pyrogenic, also containing 5 mg sodium chloride, 0.1 mg mycophenolate mofetil sodium, sorbitol, hydrochloric acid and sodium hydroxide. The product is intended for pain relief and should be stored at room temperature. This product was manufactured in Switzerland, distributed by Hospira Inc. located in the United States of America. Other parts of the text are not readable.*

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Tray - bupivacaine 20

PRINCIPAL DISPLAY PANEL - 25 mg/10 mL Vial Tray - bupivacaine 20

This is a prescription-only drug used for nerve block, caudal and epidural anesthesia. It comes in a single-use vial that is preservative-free and contains 30mL of solution. The solution contains bupivacaine HCI, 0.5% Bupivacaine eoussng sodundioride, and may contain NaOH and/or HCl for pH adjustment. The dosage is 150 mg/30 mL (5 mg/mL). It is not for spinal anesthesia. The drug should be stored at 20 to 25°C (68 to 77°F) and is distributed by Hospira, Inc. The product information indicates a lot number and expiry date.*

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Label - 1160 - bupivacaine 21

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Label - 1160 - bupivacaine 21

This is a medication labeled NDC 0409-1162-02 for nerve block, caudal and epidural anesthesia that comes in a single-dose tear-top vial of 30 mL. It is a 0.5% Bupivacaine Hydrochloride Injection, USP, containing 150 mg/30 mL (5 mg/mL) and is preservative-free. The solution contains bupivacaine hydrochloride and sodium chloride. The dosage and administration depend on the instructions of a healthcare provider. The product is sterile and non-pyrogenic. It should be stored between 20-25°C (68-77°F), and excursions between 15° and 30°C (59° and 86°F) are permitted. The rest of the text appears to be illegible or not relevant to the medication description.*

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Tray - bupivacaine 22

PRINCIPAL DISPLAY PANEL - 125 mg/50 mL Vial Tray - bupivacaine 22

This is a prescription drug called 0.5% Bupivacaine Hydrochloride Injection, USP which is used for NERVE BLOCK. The drug is distributed by Hospira, Inc., Lake Forest, IL, and each mL of it contains bupivacaine hydrochloride, anhydrous 5 mg; sodium chloride 8.1 mg; methylparaben 1mg added as a preservative. This drug is not to be used for caudal, epidural, or spinal anesthesia. The instructions on dosage, route, and administration can be found in the insert, and it should be stored at 20-25°C. The details of the lot number, expiration date, and other information are also present on the label.*

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Label - 1162 - bupivacaine 23

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Label - 1162 - bupivacaine 23

The text appears to be a drug label which contains information such as the drug name, dosage, and manufacturer's details. The drug in question contains Buphacaine Hydrochloride, an anesthetic that is used to numb tissues for surgical and medical procedures. The recommended dose and instructions for use are not available as they are mentioned in the insert. The drug should be stored at room temperature, and the label is printed in Switzerland.*

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Tray - bupivacaine 24

PRINCIPAL DISPLAY PANEL - 50 mg/10 mL Vial Tray - bupivacaine 24

This text describes a medication called Teartop Vial which is a single-dose injection that contains 0.75% Buplvacame NaOH and/or HCl for pH adjustment, sodium chloride, and hydrochloride. It is sterile and nonpyrogenic and the usual dosage and route of administration is provided in the insert. This medication is suitable for epidural and retrobulbar anesthesia but not for obstetric or spinal anesthesia. It should be stored at 20 to 25°C and is distributed by Hospira, Inc. The text also includes the lot number and expiration date.*

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Label - 1163 - bupivacaine 25

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Label - 1163 - bupivacaine 25

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Tray - bupivacaine 26

PRINCIPAL DISPLAY PANEL - 250 mg/50 mL Vial Tray - bupivacaine 26

This is a description of a single-dose teartop vial containing 0.75% Bupivacaine Hydrochloride Injection USP for epidural and retrobulbar anesthesia. Each mL of the vial contains 7.5 mg/mL of bupivacaine HCl and may also contain NaOH for pH adjustment. The vial is nonpyrogenic and preservative-free. It should be stored between 20 to 25°C (68 to 77°F) and is not recommended for obstetric or spinal anesthesia. The vial is distributed by Hospira, Inc. with a specific lot number and expiry date.*

PRINCIPAL DISPLAY PANEL - 75 mg/10 mL Vial Label - 1165 - bupivacaine 27

PRINCIPAL DISPLAY PANEL - 75 mg/10 mL Vial Label - 1165 - bupivacaine 27

Each mL contains bupivacaine hydrochloride, anhydrous 7.5 mg; sodium chloride 7.6 mg. The solution is sterile and nonpyrogenic. The solution may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The solution should be stored at 20 to 25°C (68 to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). Read the insert for more details.*

PRINCIPAL DISPLAY PANEL - 75 mg/10 mL Vial Tray - bupivacaine 28

PRINCIPAL DISPLAY PANEL - 75 mg/10 mL Vial Tray - bupivacaine 28

This is a 30 ml single-dose Teartop Vial Rxonly containing 0.25% Bupivacaine HCI and 75 mg/30 mL (2.5 mg/ml) Bupivacaine Hydrochloride and Epinephrine Injection, USP for infiltration, nerve block, caudal and epidural anesthesia. It contains sulfites and should not be autoclaved. The usual dosage should be seen in the insert. The injection should not be used if it's color is pinkish or darker than slightly yellow or if it contains a precipitate. The injection should be stored at 20 to 25°C (68 to 77°F), protected from freezing and light. It is distributed by Hospira, Inc. in Lake Forest, IL, USA.*

label NDC 0409-5757-18 - bupivacaine 29

label NDC 0409-5757-18 - bupivacaine 29

Use Aseptic Technique. The product needs to be protected from light and stored in carton until its use. Unused portions should be discarded. The recommended temperature for storage is between 15°C to 30°C. The product contains sulfates. The rest of the text is not available or not readable.*

bupivacaine 30

bupivacaine 30

This is a description of a 30 mL single-dose vial of Bupivacaine Hydrochloride and Epinephrine Injection, USP that is used for nerve blocks, caudal and epidural anesthesia. It contains 0.5% Bupivacaine HCI and 150mg/30ml, and each mL also contains epinephrine, sodium chloride, sodium metabisulfite, and edetate calcium disodium. The injection should not be autoclaved and should be discarded if it is discolored or contains a precipitate. It should be stored at a temperature between 20 to 25°C and protected from light and freezing. The warning also indicates that the injection contains sulfites.*

bupivacaine 31

bupivacaine 31

This is a product description of Bupivacaine Hydrochloride and Epinephrine Injection, USP. Each package contains a single dose of 30 ML of sterile and nonpyrogenic solution with 0.5% of Bupivacaine Hydrochloride, which includes 25 NH/mL of Epinephrine. The package number for this product is NDC0409-9045-17. The product is typically kept under warming conditions. There are additional illegible details in the text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.